Hikma Pharmaceutical | HIK - Zysk Brutto Na Sprzedaży





Zysk Brutto Na Sprzedaży Zmiana Data
Almirall EUR 429.87M 180.02M 2025-12
argenx SE USD 1.18B 40.98M 2026-03
AstraZeneca USD 12.61B 225M 2026-03
Autolus Therapeutics Ltd USD 1.65M 2.69M 2026-03
Bayer EUR 6.94B 1.58B 2025-12
Fresenius EUR 1.51B 214M 2025-12
Genmab DKK 977M 13M 2025-12
GlaxoSmithKline GBP 5.75B 429M 2026-03
GRIFOLS EUR 686.84M 56.95M 2025-12
Hikma Pharmaceutical USD 362.5M 329.5M 2025-06
Lakefront Biotherapeutics EUR 1.68M 898.68M 2026-03
Lonza CHF 1.29B 248M 2025-06
Merck EUR 3.07B 104M 2026-03
Orion EUR 339.9M 85.9M 2026-06
Recordati EUR 472.65M 40.24M 2025-12
Roche Holding CHF 22.69B 600M 2026-06
Sanofi EUR 8.45B 1.31B 2025-12
UCB EUR 3.19B 621M 2025-12